ECSP982531A - NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728) - Google Patents

NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728)

Info

Publication number
ECSP982531A
ECSP982531A ECSP982531A ECSP982531A EC SP982531 A ECSP982531 A EC SP982531A EC SP982531 A ECSP982531 A EC SP982531A EC SP982531 A ECSP982531 A EC SP982531A
Authority
EC
Ecuador
Prior art keywords
protein transferase
substituted
farnesilo
urea
case
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Alan Mallams
Stacy W Remiszewski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982531 priority Critical patent/ECSP982531A/en
Publication of ECSP982531A publication Critical patent/ECSP982531A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen novedosos compuestos de úrea halo-Nsustituida y composiciones farmacéuticas que son inhibidores de la enzima, transferasa de proteína farnesilo. También se describe un método para inhibir la función de Ras y por lo tanto inhibir el crecimiento anormal de células. El método comprende administrar el compuesto de úrea halo-N-sustituida novedoso a un sistema biológico. En particular, el método inhibe el crecimiento anormal de células en un mamífero como es un ser humano.Novel halo-N-substituted urea compounds and pharmaceutical compositions are described which are inhibitors of the enzyme, farnesyl protein transferase. Also described is a method of inhibiting Ras function and therefore inhibiting abnormal cell growth. The method comprises administering the novel halo-N-substituted urea compound to a biological system. In particular, the method inhibits abnormal cell growth in a mammal such as a human.

ECSP982531 1998-06-15 1998-06-15 NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728) ECSP982531A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982531 ECSP982531A (en) 1998-06-15 1998-06-15 NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982531 ECSP982531A (en) 1998-06-15 1998-06-15 NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728)

Publications (1)

Publication Number Publication Date
ECSP982531A true ECSP982531A (en) 1999-04-13

Family

ID=42043451

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982531 ECSP982531A (en) 1998-06-15 1998-06-15 NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728)

Country Status (1)

Country Link
EC (1) ECSP982531A (en)

Similar Documents

Publication Publication Date Title
DE60029799D1 (en) COMPOUNDS, PROCESSES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS, FOR EXAMPLE, DAMAGE TO NERVE OR CANDLE TISSUE
CA2293706A1 (en) N-substituted urea inhibitors of farnesyl-protein transferase
ATE242216T1 (en) TRICYCLIC COMPOUNDS AS INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
BR9707958A (en) Compound, pharmaceutical composition, and process for treating hyperalgesia in a patient.
BRPI0414533A (en) compound, pharmaceutical composition, and methods for inhibiting an hsp90 and treating an individual having an hsp90 mediated disorder
BR9713465A (en) Cytically substituted amine metallotprotease inhibitors
AR003938A1 (en) TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
MX9207449A (en) INHIBITORS OF THE PROTEOLYTIC ENZYME DERIVED FROM SACARINE.
MEP36908A (en) omega-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
AR002277A1 (en) USEFUL COMPOUNDS AS THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PEPTIDOMIMETIC AND PEPTIDOMIMETIC SUBSTANCES OF SERINPROTEASE.
BR0317284A (en) Mitogen-Activated Protein Kinase-2 Aminocyanopyridine Inhibitors
BR0009244A (en) Diheter metalloprotease inhibitors replaced
TR199901274T2 (en) New tricyclic piperidinyl compounds useful as farnesyl protein transferase inhibitors
AR012989A1 (en) NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL-PROTEIN TRANSFERASE.
ATE299140T1 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
Sonnemann et al. The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro
ECSP982531A (en) NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728)
BR0308601A (en) plasma carboxypeptidase b inhibitors
HN1997000070A (en) INHIBITION OF MATRIX METALOPROTEINASES BY ACIDS 2 - ((1) -AROYLALKYL) -4-BIARYL-4-OXOBURITICS
ES2054904T3 (en) PROCEDURE FOR THE PREPARATION OF PEPTIDES WITH ACTIVITY INHIBITOR OF ENZYMATIC SYSTEMS.
CO4900031A1 (en) NEW TRICYCLIC N-CYANOIMINES USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO
ECSP982530A (en) NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASA
He et al. L-NMMA and 1400W, inhibitors of iNOS, attenuate the induction of iNOS and NO in primary rabbit costal chondrocytes by fluoride
ES2196566T3 (en) NEW TRICYCLE COMPOUNDS OF AMINOOXIAMIDA INHIBITORS OF FARNESIL-PROTEINA-TRANSFERASA.
ECSP982536A (en) USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K)